Although the region of PSA levels from 4 to 10 ng/mL is defined as a “gray zone” according to the traditional concepts, the prostate cancer detection rate of the patients with PSA levels of 10–20 ng/mL is not superior to the patients whose PSA levels in the “gray zone” conspicuously. The gene discussed is KLK3; the disease is Familial prostate cancer.